Grant Street Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
214
-57
-21% -$58.2K 0.04% 78
2026
Q1
$249K Sell
271
-56
-17% -$56.8K 0.05% 79
2025
Q4
$351K Buy
+327
New +$313K 0.07% 62
2021
Q2
– Sell
-86
Closed -$16K – 120
2021
Q1
$16K Hold
86
– – 0.01% 179
2020
Q4
$15K Buy
+86
New +$12.8K 0.01% 154

Other funds holding LLY

Grant Street Asset Management's LLY Position: Q2 2026 in Review

Grant Street Asset Management reduced its Eli Lilly (LLY) stake by 21% in Q2 2026, selling an estimated $58.2K and leaving 214 shares worth $257K. The position accounts for 0.04% of the portfolio, ranked #78.

Grant Street Asset Management first reported a position in LLY in Q4 2020 and has held it in 5 quarters since. The position peaked at $351K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Grant Street Asset Management held 214 shares of Eli Lilly worth $257K as of Q2 2026.
  • Grant Street Asset Management sold 57 Eli Lilly shares in Q2 2026, an estimated $58.2K.
  • Eli Lilly made up 0.04% of Grant Street Asset Management's portfolio in Q2 2026, its #78 holding.
  • Grant Street Asset Management first reported a position in Eli Lilly in Q4 2020 and has held it in 5 quarters since.
  • Grant Street Asset Management's Eli Lilly position peaked at $351K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Grant Street Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.